Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease (Q24242947)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943766%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

1 reference

title

Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943766%20AND%20SRC:MED&resulttype=core&format=json

amyotrophic lateral sclerosis

9 January 2020

main subject

0 references

1 reference

J D Mitchell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943766%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

17 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943766%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943766%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943766%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

CD002064

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943766%20AND%20SRC:MED&resulttype=core&format=json

Beneficial effects of intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002064.PUB2

Geographic distribution of motor neuron disease and correlation with possible etiologic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002064.PUB2

Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002064.PUB2

Activity-sensitive signaling by muscle-derived insulin-like growth factors in the developing and regenerating neuromuscular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002064.PUB2

Distribution and levels of insulin-like growth factor (IGF-I and IGF-II) and insulin receptor binding sites in the spinal cords of amyotrophic lateral sclerosis (ALS) patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002064.PUB2

Natural history of amyotrophic lateral sclerosis in a database population Validation of a scoring system and a model for survival prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002064.PUB2

Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002064.PUB2

Insulin-like growth factor-I: potential for treatment of motor neuronal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002064.PUB2

Relationship of the Tufts Quantitative Neuromuscular Exam (TQNE) and the Sickness Impact Profile (SIP) in measuring progression of ALS. SSNJV/CNTF ALS Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002064.PUB2

Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology committee on Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002064.PUB2

Geographical epidemiology of residence of patients with motor neuron disease in Lancashire and south Cumbria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002064.PUB2

A rating scale for amyotrophic lateral sclerosis: description and preliminary experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002064.PUB2

7 January 2021

Insulin-like growth factors: putative muscle-derived trophic agents that promote motoneuron survival

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002064.PUB2

7 January 2021

Insulin-like growth factor-1 receptors in human spinal cord: changes in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002064.PUB2

7 January 2021

Beneficial effects of insulin-like growth factor-I on wobbler mouse motoneuron disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002064.PUB2

7 January 2021

Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002064.PUB2

7 January 2021

A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002064.PUB2

7 January 2021

10.1002/14651858.CD002064.PUB2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943766%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference